Biologically, the BRD7-USP1-CHK1 axis regulates the sensitivity of tumor cells to chemotherapeutic drugs targeting CHK1, suggesting BRD7 as a new potential molecular target for effective anti-cancer therapy. This evidence concerns the gene BRD7 and neoplasm.